Multicomponent diastereoselective synthesis of tetrahydropyridines as α-amylase and α-glucosidase enzymes inhibitors

Future Med Chem. 2023 Aug;15(15):1343-1368. doi: 10.4155/fmc-2023-0073. Epub 2023 Aug 31.

Abstract

Background: Researchers seeking new drug candidates to treat diabetes mellitus have been exploring bioactive molecules found in nature, particularly tetrahydropyridines (THPs). Methods: A library of THPs (1-31) were synthesized via a one-pot multicomponent reaction and investigated for their inhibition potential against α-glucosidase and α-amylase enzymes. Results: A nitrophenyl-substituted compound 5 with IC50 values of 0.15 ± 0.01 and 1.10 ± 0.04 μM, and a Km value of 1.30 mg/ml was identified as the most significant α-glucosidase and α-amylase inhibitor, respectively. Kinetic studies revealed the competitive mode of inhibition, and docking studies revealed that compound 5 binds to the enzyme by establishing hydrophobic and hydrophilic interactions and a salt bridge interaction with His279. Conclusion: These molecules may be a potential drug candidate for diabetes in the future.

Keywords: in silico; in vitro; kinetic studies; pyridine; α-amylase activity; α-glucosidase activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus*
  • Glycoside Hydrolase Inhibitors* / chemistry
  • Humans
  • Kinetics
  • Molecular Docking Simulation
  • Structure-Activity Relationship
  • alpha-Amylases / antagonists & inhibitors
  • alpha-Glucosidases / metabolism

Substances

  • alpha-Amylases
  • alpha-Glucosidases
  • Glycoside Hydrolase Inhibitors